Join the club for FREE to access the whole archive and other member benefits.


Company that develops a single-cell detection system identifying patient immune responses

IsoPlexis is dedicated to accelerating the fight against cancer and a range of the world’s toughest diseases with our uniquely correlative, award-winning single-cell detection systems. By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise & personalized stage. Our integrated systems, named #1 innovation by the Scientist Magazine & Fierce, are used globally to advance the field of single-cell biology and biomarkers as we generate solutions to overcome the challenges of complex diseases.

Visit website:


Details last updated 22-Oct-2019

IsoPlexis News

State of play of single-cell sequencing technology

Labiotech - 14-Oct-2019

Extreme personalised medicine realises there is no such thing as an average cell

Topics mentioned on this page:
Precision Medicine, Stem Cells